Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Masayo Yamada, Audrey Wu Li & Jack R. Wall. (2000) Thyroid-Associated Ophthalmopathy: Clinical Features, Pathogenesis, and Management. Critical Reviews in Clinical Laboratory Sciences 37:6, pages 523-549.
Read now
Read now
Sandra M. McLachlan, Mark F. Prummel, Richard L. Dallow, Wilmar M. Wiersinga & Basil Rapoport. (1993) Amplification by Polymerase Chain Reaction of Immunoglobulin Heavy and Light Chain Genes from Orbital Tissue of Patients with Graves' Ophthalmopathy. Autoimmunity 16:2, pages 149-152.
Read now
Read now
Articles from other publishers (28)
Natalya Alexandrovna Bakunina & Lidiya Nikolaevna Kolesnikova. (2015) The immunotherapy role in ocular hypertension management. Ophthalmology Reports 8:3, pages 72-81.
Crossref
Crossref
M Anvari, O Khalilzadeh, A Esteghamati, S A Esfahani, A Rashidi, A Etemadi, M Mahmoudi & A A Amirzargar. (2009) Genetic susceptibility to Graves’ ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes. Eye 24:6, pages 1058-1063.
Crossref
Crossref
Mário L. R. Monteiro, Hélio Angotti-Neto, Joseph E. Benabou & Alberto J. Betinjane. (2008) Color Doppler imaging of the superior ophthalmic vein in different clinical forms of Graves’ orbitopathy. Japanese Journal of Ophthalmology 52:6, pages 483-488.
Crossref
Crossref
Patricia Mitiko Santello AkaishiAntonio Augusto Velasco CruzFabricio Leon Mascaro SilvaMaria de Lourdes Veronesi RodriguesLea Maria Zanini MacielEduardo Antonio Donadi. (2008) The Role of Major Histocompatibility Complex Alleles in the Susceptibility of Brazilian Patients to Develop the Myogenic Type of Graves' Orbitopathy. Thyroid 18:4, pages 443-447.
Crossref
Crossref
S. El-Kaissi, A. G. Frauman & J. R. Wall. (2004) Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Internal Medicine Journal 34:8, pages 482-491.
Crossref
Crossref
Darcie D Streetman & Ujjaini Khanderia. (2003) Diagnosis and Treatment of Graves Disease. Annals of Pharmacotherapy 37:7-8, pages 1100-1109.
Crossref
Crossref
Jane Pritchard, Rui Han, Noah Horst, William W. Cruikshank & Terry J. Smith. (2003) Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves’ Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway. The Journal of Immunology 170:12, pages 6348-6354.
Crossref
Crossref
Masayo Yamada, Audrey Li, Cheng-Hsien Chang & Jack Wall. 2002. Thyroid Eye Disease. Thyroid Eye Disease
223
233
.
R. Villanueva, A.M. Inzerillo, Y. Tomer, G. Barbesino, M. Meltzer, E.S. Concepcion, D.A. Greenberg, N. MacLaren, Z.S. Sun, D.M. Zhang, S. Tucci & T.F. Davies. (2000) Limited Genetic Susceptibility to Severe Graves' Ophthalmopathy: No Role for CTLA-4 But Evidence for an Environmental Etiology. Thyroid 10:9, pages 791-798.
Crossref
Crossref
Yaron Tomer & Terry F. Davies. 2000. Graves’ Disease. Graves’ Disease
19
41
.
Yaron Tomer, David A. Greenberg & Terry F. Davies. 1999. Autoimmune Endocrinopathies. Autoimmune Endocrinopathies
57
90
.
TAKU KASHIWAI, HISATO TADA, YUKIHIKO WATANABE, YUKI SHIMAOKA, AYA YAGORO, YOH HIDAKA, TAKASHI FUJIKADO & NOBUYUKI AMINO. (1998) Low Response of the Thyroid Gland to Endogenous Thyrotropin Increased by Thyrotropin-Releasing Hormone in Patients with Euthyroid Graves' Disease. Thyroid 8:10, pages 881-885.
Crossref
Crossref
R. M. Cuddihy & R. S. Bahn. 1998. Endocrine Autoimmunity and Associated Conditions. Endocrine Autoimmunity and Associated Conditions
99
111
.
Yaron Tomer & Terry F. Davies. (1997) The genetic susceptibility to Graves' disease. Baillière's Clinical Endocrinology and Metabolism 11:3, pages 431-450.
Crossref
Crossref
Bernard J. Major, Alina Cures & Albert G. Frauman. (1997) The Full Length and Splice Variant Thyrotropin Receptor Is Expressed Exclusively in Skeletal Muscle of Extraocular Origin: A Link to the Pathogenesis of Graves’ Ophthalmopathy. Biochemical and Biophysical Research Communications 230:3, pages 493-496.
Crossref
Crossref
SHIGEKI MORI, NORIO YOSHIKAWA, TOSHIKO TOKORO, SUSUMU IKEHARA, YOICHI INOUE, MITSUSHIGE NISHIKAWA & MITSUO INADA. (1996) Studies of Retroorbital Tissue Xenografts from Patients with Graves' Ophthalmopathy in Severe Combined Immunodeficient (SCID) Mice: Detection of Thyroid-Stimulating Antibody. Thyroid 6:4, pages 275-281.
Crossref
Crossref
A. Barsouk, K. A. Peele, J. Kiljanski, C. Stolarski, V. Nebes, J. S. Kennerdell, R. Volpe & J. R. Wall. (2014) Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction. Journal of Endocrinological Investigation 19:6, pages 334-341.
Crossref
Crossref
MIKIO WATANABE, YOSHINORI IWATANL, TAKU KASHIWAI, TAKASHI IIJIMA, TAKASHI FUJIKADO & NOBUYUKI AMINO. (2009) Euthyroid Graves' disease showing no thyroid abnormalities except positive thyroid‐stimulating antibody (TSAb): two case reports. Journal of Internal Medicine 238:4, pages 379-384.
Crossref
Crossref
ARMIN E. HEUFELDER. (1995) Involvement of the Orbital Fibroblast and TSH Receptor in the Pathogenesis of Graves' Ophthalmopathy. Thyroid 5:4, pages 331-340.
Crossref
Crossref
A. BARSOUK, S. WENGROWICZ, D. SCALISE, C. STOLARSKI, V. NEBES, M. SATO & J. R. WALL. (1995) New Assays for the Measurement of Serum Antibodies Reactive with Eye Muscle Membrane Antigens Confirm Their Significance in Thyroid-Associated Ophthalmopathy. Thyroid 5:3, pages 195-200.
Crossref
Crossref
CHRISTA I. UTECH, UTA KHATIBNIA, PETER F. WINTER & KLAUS G. WULLE. (1995) MR T2 Relaxation Time for the Assessment of Retrobulbar Inflammation in Graves' Ophthalmopathy. Thyroid 5:3, pages 185-193.
Crossref
Crossref
I. Molnár, V. Kaczur, A. Boros, G. Krajczár & C. Balázs. (2014) IgA autoantibodies against human eye muscle antigen detected by western blotting and immunohistochemical methods in Graves’ disease. Journal of Endocrinological Investigation 18:6, pages 408-414.
Crossref
Crossref
Mark F. Prummel, Gregorio Chazenbalk, Juan Carlos Jaume, Basil Rapoport & Sandra M. McLachlan. (1994) Profile of lambda light chain variable region genes in graves' orbital tissue. Molecular Immunology 31:11, pages 793-802.
Crossref
Crossref
N. Tandon, S. L. Yan, K. Arnold, R. A. Metcalfe & A. P. Weetman. (1994) Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy. Clinical Endocrinology 40:5, pages 629-639.
Crossref
Crossref
Dennis R. Burton & Carlos F. BarbasIIIIII. 1994. Advances in Immunology Volume 57. Advances in Immunology Volume 57
191
280
.
Franklin H. Epstein, Rebecca S. Bahn & Armin E. Heufelder. (1993) Pathogenesis of Graves' Ophthalmopathy. New England Journal of Medicine 329:20, pages 1468-1475.
Crossref
Crossref
S. Davris, H. Riechelmann, W. Mann & G. Kahaly. (2018) Sinusitis in Thyroid Associated Ophthalmopathy. American Journal of Rhinology 7:5, pages 233-235.
Crossref
Crossref
D Munro. (1993) Thyroid eye disease.. BMJ 306:6881, pages 805-806.
Crossref
Crossref